PhaseOut DMD: a Phase 2, proof of concept, clinical study of utrophin modulation with ezutromidF. Muntoni, Jonathon M. Tinsley, Gary Layton et al.|Neuromuscular Disorders|2017Cited by 9
Utrophin modulators to treat Duchenne muscular dystrophy (DMD): Results from a Phase 1b Clinical Trial of SMT C1100Jonathon M. Tinsley, Kelvin J.A. Davies, F. Muntoni et al.|Neuromuscular Disorders|2015Cited by 0